Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients

被引：0
|
作者：
Cargnel, A
Angeli, E
Mainini, A
Gubertini, G
Giorgi, R
Orlando, G
Duca, P
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83871-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A766 / A766
页数：1
相关论文
共 50 条
  • [11] Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
    Voigt, Esther
    Schulz, Christian
    Klausen, Gerd
    Goelz, Joerg
    Mauss, Stefan
    Schmutz, Guenther
    Jessen, Heiko
    Weitner, Lutwin
    Mutz, Antonius
    Schranz, Dietmar
    Rockstroh, Juergen K.
    JOURNAL OF INFECTION, 2006, 53 (01) : 36 - 42
  • [12] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [13] Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were nonresponders to previous therapy
    Lawitz, EJ
    Cantu, NS
    Becker, S
    Dhar, R
    Li, J
    Bala, NS
    Gordon, S
    Davis, M
    Nader, P
    Holtzmuller, K
    Rosenfield, T
    Monsour, H
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [14] Prevalence of thyroid dysfunction in patients with chronic hepatitis C infection receiving pegylated interferon alpha 2a versus alpha 2b, plus ribavirin
    Gan, E. K.
    Miczkova, S.
    Andrews, G.
    Booth, L.
    Mollison, L. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A271 - A271
  • [15] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [16] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [17] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [18] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [19] Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
    Annicchiarico, BE
    Siciliano, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 123 - 124
  • [20] HCV-RNA and inflammasome is modulated by PEGylated interferon (PEG-IFNα-2b) monotherapy in chronic hepatitis c patients
    Manuela, G. Neuman
    Katz, Gadi G.
    Patel, Ankit
    Malkiewicz, M. Izabella
    Esguerra, Rustan
    CLINICAL BIOCHEMISTRY, 2010, 43 (09) : 781 - 781
12345